Autoimmune Disease

Gene rearrangement could lead the way to a cure for systemic lupus

Published in Gene Therapy Weekly, July 31st, 2003

Gene rearrangement could lead the way to a cure for systemic lupus.

"Activation of T cells from patients with systemic lupus erythematosus (SLE) leads to increased signaling responses, detected by increased calcium and protein tyrosine phosphorylation patterns. This overexcitability occurs in spite of decreased levels of T-cell receptor zeta chain," investigators in the United States report.

"The replacement of the zeta chain by the Fc receptor (FcR) gamma chain and the formation of signaling molecule aggregates on the surface of T cells are considered to be responsible for the observed signaling phenotype," according to G.C. Tsokos and colleagues,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2003-07-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry